Vaishali Pharma Share Price Today

Vaishali Pharma allots 45.37 lakh shares at ₹20 each to Kesar Pharma

Vaishali Pharma allotted 45,37,865 equity shares at ₹20 each to Kesar Pharma to acquire a 26.95% stake, increasing its paid-up capital to ₹26,99,99,990.

Vaishali Pharma adjusts allotment consideration based on valuation report

Vaishali Pharma Ltd will receive ₹2,15,258 from Kesar Pharma Ltd to align preferential allotment consideration with a registered valuer's report. The adjustment addresses a ₹0.10 per share difference on 21,52,575 shares acquired.

Vaishali Pharma seeks nod for director re-appointments, pay revision

Vaishali Pharma Limited has announced a postal ballot to secure shareholder approval for the re-appointment of Mr. Pratik Vikram Jakhelia as Independent Director, Mr. Atul Arvind Vasani as Managing Director, and Mrs. Jagruti Vasani as Whole-Time Director, along with a remuneration hike for Director cum CFO Mr. Dewansh Ajay Vasani. The e-voting process runs from June 4 to July 3, 2026, with results expected by July 7, 2026. The proposed remuneration for the Managing Director and Whole-Time Director exceeds statutory limits, requiring approval via special resolution.

Vaishali Pharma FY26 net profit rises to ₹403.17 lakh

Vaishali Pharma Limited reported a net profit of ₹403.17 lakh for FY26, up from ₹81.74 lakh in FY25, with revenue rising to ₹10,877.23 lakh. The auditors raised concerns about substantial receivables overdue for over three years. Consolidated results include the associate Kesar Pharma Limited.

Vaishali Pharma board approves re-appointment of three directors

Vaishali Pharma's Board approved the re-appointment of Managing Director Atul Arvind Vasani, Whole-Time Director Jagruti Vasani, and Independent Director Pratik Vikram Jakhelia for five-year terms. The appointments, effective from May 23, 2026, and September 30, 2026, are subject to shareholder approval. The company disclosed relationships among the directors and confirmed compliance with SEBI regulations.